Why TherapeuticsMD Is Skyrocketing
TherapeuticsMDwas leading the health care sector in Tuesday’s session on positive top-line results from one of its late-stage trials.
All Work
Chris Lange
Why Onconova Is Soaring
Onconova Therapeutics led the bulls early in Tuesday’s trading session on positive data from an ongoing Phase 1/2 clinical trial.
AutoZone Expansion Rings Up Earnings Beat
AutoZone reported mixed fiscal first-quarter financial results before the markets opened on Tuesday.
Conns Sinks on Earnings Miss
Conns reported disappointing fiscal third-quarter financial results before the markets opened on Tuesday.
H&R Block Loss Precipitates Sliding Shares
H&R Block reported disappointing fiscal second-quarter financial results after the markets closed on Monday.
Jefferies Top Pharma Stock Picks for 2016
Brokerage firm Jefferies has released its top pharmaceutical picks for the coming year and what to expect.
SEC Charges Lawyers Acting as Unregistered Brokers
The SEC announced a series of enforcement actions against lawyers across the United States charged with offering EB-5 investments while not registered to act as brokers.
Why Key Analyst Still Sees Some Upside in Bluebird Bio
Bluebird Bio absolutely tanked in Monday's trading session, based on preclinical and manufacturing data from the American Society of Hematology Annual Meeting.
Why Threshold Pharma Is Imploding
Threshold Pharmaceuticals watched its stock completely collapse in Monday’s session after a joint late-stage study failed to yield positive results.
Idera Pharma Soars Over Positive Trial Data
Idera Pharmaceuticals made a strong push in Monday’s session following the presentation of its clinical data over the weekend.
MEI Pharma Bounces Off Lows After Positive Phase 2 Results
MEI Pharma Inc. (NASDAQ: MEIP) was leading the bulls in the broad markets Monday on news of positive Phase 2 results. The company announced positive results from a study of its investigational drug candidate…
Mattress Firm Earnings Not Enough for Investors
Mattress Firm released better-than-expected fiscal third-quarter earnings report before the markets opened on Monday.
Vail Resorts Wows Investors Despite Loss
Vail Resorts reported better-than-expected fiscal first-quarter financial results before the markets opened on Monday.
Does Chipotle Have Even More Downside Than Previously Thought?
Chipotle Mexican Grill issued updated guidance on where it stands with its E. coli outbreak, and things look much worse than previously thought.
Are Keurig Shareholders Getting Enough?
Keurig Green Mountain is going private in a deal worth approximately $14 billion, but are shareholders getting enough?
Top 7 Earnings Previews for the Week Ahead
24/7 Wall St. has put together a preview of Marvell Technology, Lululemon Athletica and other major companies reporting their quarterly results this week.
Top 6 BioPharma Movers of the Week
These biotech companies stood out from the rest with incredible gains or losses over the course of the past week.
Is Aflac Still a Buy?
Aflac Inc. (NYSE: AFL) recently gave its outlook, but considering a weakening yen over the past month, analysts have become wary. Janney Capital recently reduced its earnings per share (EPS) estimate to $6.30 from…
NRG Continues to Fall as CEO Steps Down
NRG Energy has announced that David Crane is stepping down as president and chief executive officer, effective immediately.
Why Oppenheimer Wants to Chase Warren Buffett in Phillips 66
Phillips 66 has long been a staple of Warren Buffett's portfolio and it is now attracting the attention of an Oppenheimer analyst.